Mounjaro vs Wegovy Dosage: Which Protocol Fits Your Lifestyle?
Private Prescription Access: Mounjaro vs Wegovy Dosage Without NHS Delays
The fundamental difference between accessing Mounjaro vs Wegovy dosage through private prescription versus the NHS lies in speed and convenience. NHS patients typically face a 6+ month journey: GP referral, specialist weight management service assessment, and strict BMI criteria enforcement before accessing either treatment. Private prescription eliminates these barriers entirely, offering direct access to qualified prescribers who can evaluate both Mounjaro and Wegovy dosing protocols within 24-72 hours.
Private prescription also allows for more flexible dosing discussions, where prescribers can consider individual lifestyle factors, travel requirements, and personal preferences when recommending between Mounjaro's dual-hormone approach and Wegovy's established GLP-1 protocol. This personalised assessment ensures you receive the most suitable dosing schedule for your circumstances, rather than being constrained by NHS formulary restrictions or regional availability differences.
Wegovy Dosage Pricing Structure and Bundle Value
Wegovy's escalating dosage schedule means pricing increases with each dose strength, starting at £79.99 for the 0.25mg starter dose (with FIRST40 code applied at checkout for new customers). The progression follows: 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the maintenance 2.4mg dose at £209.99. This pricing structure reflects the increasing API content and manufacturing complexity of higher-strength pens. Returning customers benefit from the DOSE25 discount code, reducing costs across all dose levels.
Our Intro Trio bundle (0.25mg, 0.5mg, and 1mg) provides the first three months of treatment for £299.99, offering convenience and Reliable Supply continuity. The Ultimate Stability Trio delivers three months of maintenance 2.4mg treatment for £649.99, ideal for patients who have successfully completed dose escalation. These bundles eliminate the need for monthly reordering and ensure uninterrupted treatment during dose transitions.
Clinical Evidence: STEP Trial Outcomes for Wegovy Dosage Protocol
The STEP clinical trial programme demonstrated Wegovy's efficacy across its complete dosing schedule, with participants following the exact escalation protocol available through private prescription in the UK. In STEP 1, patients taking Wegovy alongside diet and exercise achieved an average of clinically studied weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The study specifically validated the importance of the dose escalation schedule for tolerability and efficacy.
STEP 5 confirmed the sustainability of Wegovy's dosing protocol, showing 15.2% average weight loss maintained at 2 years when patients continued with the weekly 2.4mg maintenance dose. These results underscore why the complete dosing journey, from 0.25mg through to 2.4mg, forms an integral part of Wegovy's licensed indication and cannot be abbreviated or modified without medical supervision.
How Wegovy Works: GLP-1 Mechanism Across All Dose Levels
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking the action of a natural hormone that signals fullness to the brain. This mechanism operates across all dose levels, from the initial 0.25mg through to the maintenance 2.4mg, with higher doses providing more sustained appetite suppression and enhanced satiety signals. The medication works by slowing gastric emptying, which prolongs the feeling of fullness after meals, and directly influences the hypothalamic appetite centres to reduce food cravings. The dose escalation schedule allows patients to gradually adapt to these effects while minimising gastrointestinal side effects. Unlike combination therapies, Wegovy's singular focus on GLP-1 pathways provides a well-established and extensively researched approach to weight management that has been refined through multiple clinical trials and real-world usage data.
Private Prescription Ordering Process: From Assessment to Delivery
EverydayMeds' private prescription process begins with a comprehensive 3-minute clinical assessment that evaluates your suitability for either Mounjaro or Wegovy, including discussion of appropriate starting doses and escalation schedules. Our qualified prescribers review your submission within standard 3 working days (or 24 hours with express service), considering your medical history, current medications, and weight management goals to recommend the most appropriate treatment and dosing protocol. Once approved, your prescription is fulfilled by our GPhC-registered pharmacy (#9012878) using the same quality standards and safety protocols as NHS prescriptions. All Wegovy pens are shipped via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity and potency. This streamlined process eliminates the traditional barriers of GP appointments, specialist referrals, and lengthy waiting lists while maintaining full clinical oversight and safety standards.
Storage and Practical Considerations: Wegovy Dose Management
Wegovy pens require refrigeration at 2-8°C before first use but offer exceptional travel convenience with 6 weeks of room temperature stability once removed from the fridge (compared to Mounjaro's 21-day limit). This storage advantage makes Wegovy particularly suitable for frequent travelers or those with unpredictable schedules who need flexibility in their dosing routine. Each pen contains four doses, with the FlexTouch delivery system providing accurate dosing across all strength levels from 0.25mg through 2.4mg. The dose escalation must follow the prescribed schedule, with each dose level maintained for exactly four weeks before progression to prevent tolerability issues. Patients should never attempt to accelerate the dosing schedule or skip intermediate levels, as this can significantly increase the risk of gastrointestinal side effects and may compromise treatment outcomes.
Why Choose Private Prescription for Mounjaro vs Wegovy Dosage Decisions
Private prescription offers unique advantages when comparing Mounjaro vs Wegovy dosage options, particularly around prescriber accessibility and treatment flexibility. Unlike NHS pathways where formulary restrictions may limit choice between treatments, private prescribers can objectively assess both Mounjaro's dual GIP/GLP-1 approach and Wegovy's established GLP-1 protocol based purely on clinical suitability. This freedom allows for more nuanced discussions about dosing schedules, lifestyle compatibility, and individual response patterns.
The transparency of private prescription pricing also enables informed decision-making about long-term treatment costs, with clear visibility of dose escalation expenses and maintenance therapy investments. Patients can plan their treatment journey financially while receiving the same quality medications and clinical oversight as NHS patients, but without the uncertainty of waiting lists or regional availability issues that may affect treatment continuity.
Complete Your Wegovy Journey: Next Steps and Clinical Support
Ready to begin your Wegovy treatment with full private prescription support? Our clinical team stands ready to guide you through the complete dosing protocol, from initial 0.25mg assessment through to long-term maintenance at 2.4mg. Use code FIRST40 at checkout for new customers or DOSE25 for returning patients to access our transparent pricing structure. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and connect with our qualified prescribers who can help determine whether Wegovy's dosing schedule aligns with your weight management goals. With next-day delivery and ongoing clinical support, your treatment journey can begin immediately. Both Wegovy and Mounjaro are available through EverydayMeds, and our prescribers can help you choose the most appropriate option based on your individual circumstances and clinical needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
